6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis
NCT00170872 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 135
Last updated 2012-05-21
Summary
This study tested the safety, tolerability and efficacy of lumiracoxib - a COX-2 inhibitor- in patients with primary knee osteoarthritis or rheumatoid arthritis.
Conditions
Interventions
- DRUG
-
Lumiracoxib
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharma AG · Sponsor GmbH
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-11-30
- Primary Completion
- 2005-07-31
More Related Trials
-
52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine
NCT00145301 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension
NCT00267176 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis
NCT00154219 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Lumiracoxib in Patients With Osteoarthritis
NCT00637949 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery
NCT00333567 ·Status: COMPLETED ·Phase: PHASE4
-
Tanezumab In Osteoarthritis Of The Knee (2)
NCT00830063 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA
NCT04097379 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
NCT00120900 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of G001 in Patients With Osteoarthritis (OA) of the Knee
NCT05007808 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen
NCT00640627 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen
NCT00638807 ·Status: COMPLETED ·Phase: PHASE4
-
Tanezumab in Osteoarthritis of the Knee
NCT00733902 ·Status: COMPLETED ·Phase: PHASE3
-
First-in-human, Safety, Tolerability and Pharmacokinetics Study of LRX712 in Osteoarthritic Patients
NCT03355196 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee
NCT00928837 ·Status: COMPLETED ·Phase: NA
-
Celebrex Total Knee Arthroplasty Study
NCT00359151 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain
NCT02192190 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee
NCT00435292 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis
NCT00643799 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients
NCT03037489 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA
NCT05237752 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
NCT00689273 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee
NCT04119687 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The Knee
NCT01438918 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension
NCT00419796 ·Status: COMPLETED ·Phase: PHASE4
-
A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the Knee
NCT06704932 ·Status: COMPLETED ·Phase: PHASE1